Neuroimaging Features and Predictors of Outcome in Eclamptic Encephalopathy: A Prospective Observational Study

REFERENCES

1. 1.↵
   Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1–22

   CrossRefPubMedWeb of Science
2. 2.↵
   World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva, Switzerland: World Health Organization; 2011
3. 3.↵
   1. Schwartz RB,
   2. Jones KM,
   3. Kalina P,
   4. et al

   . Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–83

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Schwartz RB,
   2. Feske SK,
   3. Polak JF,
   4. et al

   . Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371–76

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Hinchey J,
   2. Chaves C,
   3. Appignani B,
   4. et al

   . A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Dillon WP,
   2. Rowley H

   . The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 1998;19:591

   PubMedWeb of Science
7. 7.↵
   1. Casey SO,
   2. Sampaio RC,
   3. Michel E,
   4. et al

   . Posterior reversible encephalopathy syndrome: utility of FLAIR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–206

   Abstract/FREE Full Text
8. 8.↵
   1. Demirtaş O,
   2. Gelal F,
   3. Vidinli BD,
   4. et al

   . Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagn Interv Radiol 2005;11:189–94

   PubMed
9. 9.↵
   1. Petrovic BD,
   2. Nemeth AJ,
   3. McComb EN,
   4. et al

   . Posterior reversible encephalopathy syndrome and venous thrombosis. Radiol Clin N Am 2011;49:63–80

   PubMed
10. 10.↵
    1. Gao B,
    2. Liu FL,
    3. Zhao B

    . Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience. Eur J Radiol 2012;81:2844–47

    PubMed
11. 11.↵
    1. Jaiswar SP,
    2. Gupta A,
    3. Sachan R,
    4. et al

    . Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia. J Obstet Gynaecol India 2011;61:645–48

    PubMed
12. 12.↵
    ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia. number 33, January 2002. Obstet Gynecol 2002;99:159–67

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Haram K,
    2. Svendsen E,
    3. Abildgaard U

    . The HELLP syndrome: clinical issues and management: a review. BMC Pregnancy Childbirth 2009;9:8

    CrossRefPubMed
14. 14.↵
    1. McKinney AM,
    2. Short J,
    3. Truwit CL,
    4. et al

    . Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904–12

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Duley L

    . Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial. Br J Obstet Gynaecol 1996;103:103–05

    PubMedWeb of Science
16. 16.↵
    1. Chakravarty A,
    2. Chakrabarti SD

    . The neurology of eclampsia: some observations. Neurol India 2002;50:128–35

    PubMed
17. 17.↵
    1. Sibai BM

    . Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–92

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Feske SK

    . Posterior reversible encephalopathy syndrome: a review. Semin Neurol 2011;31:202–15

    CrossRefPubMed
19. 19.↵
    1. Bartynski WS,
    2. Boardman JF

    . Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320–27

    Abstract/FREE Full Text
20. 20.↵
    1. Bartynski WS

    . Posterior reversible encephalopathy syndrome. Part 1. Fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:1036–42

    Abstract/FREE Full Text
21. 21.↵
    1. Hefzy HM,
    2. Bartynski WS,
    3. Boardman JF,
    4. et al

    . Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol 2009;30:1371–79

    Abstract/FREE Full Text
22. 22.↵
    1. McKinney AM,
    2. Sarikaya B,
    3. Gustafson C,
    4. et al

    . Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:896–903

    Abstract/FREE Full Text
23. 23.↵
    1. Brewer J,
    2. Owens MY,
    3. Wallace K,
    4. et al

    . Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013;208:468.e1–6
24. 24.↵
    1. Schaefer PW,
    2. Buonanno FS,
    3. Gonzalez RG,
    4. et al

    . Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082–85

    Abstract/FREE Full Text
25. 25.↵
    1. Ay H,
    2. Buonanno FS,
    3. Schaefer PW,
    4. et al

    . Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369–76

    CrossRef
26. 26.↵
    1. Sengar AR,
    2. Gupta RK,
    3. Dhanuka AK,
    4. et al

    . MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–90

    Abstract